New Product Launches
Date: November 2013
KOBEC Health Sciences has always been on the forefront of introducing quality ocular products. We have kept up with this tradition by launching another quality antibiotic named XEMOX Strerile Ophthalmic Solution (Moxifloxacin 0.5%) in Nov, 2013. XEMOX (Moxifloxacin 0.5%) is a 4th generation fluoroquinolone and is indicated for bacterial conjuctivitis with added advantage of HPMC for better drug contact time, soothing effect and tolerability.
Date: March 2013
KOBEC Health Sciences has successfully launched a new ocular lubricant named Tearkool across Pakistan, which is a complete package to manage mild to moderate cases of dry eye syndrome. Tearkool contains hypromellose 0.3% that brings comfort to dry eyes due to a safe, excellent and unique disappearing preservative.
Date: 14th November, 2011
KOBEC always strives hard to introduce innovative and quality products for the well-being of patients. To keep up with this momentum we have launched a novel NSAID for deep and strong penetration with the name of Nepanac that contains Nepafenac sodium 0.1% for the treatment and better management of pain and inflammation.
Date: 24th August, 2011
KOBEC Health Sciences successfully launches Loxiget Forte (Gatifloxacin 0.5%) across Pakistan. Loxiget Forte (Gatifloxacin 0.5%) belongs to the fourth generation of flouroquinolones. This is for the 1st time in Pakistan that a product has been launched which is the latest ophthalmic antibiotic drops approved by FDA indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of bacteria. Loxiget has a unique dual mode of action i.e. Inhibition of Topoisomerase IV and DNA Gyrase.
